Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in GNLX — GENELUX Corp

CIK 886982 NEW YORK, NY
Back to GNLX Full portfolio

Position in GNLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$137,885
+$58,969 QoQ
Shares Held
45,809
+40.5% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 72 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GNLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. GNLX ranks #325 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in GNLX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $137,885 45,809
2026-03-31 $78,916 32,610
2025-12-31 $801,398 183,807
2025-09-30 $140,044 33,344
2025-06-30 $43,159 15,038
2025-03-31 $238,850 88,463
2024-06-30 $351,477 180,245
2024-03-31 $84,785 13,186
2023-09-30 $621,629 25,383
2023-03-31 $239,867 8,647